TG Therapeutics EPS - Earnings per Share 2010-2024 | TGTX
- TG Therapeutics EPS for the quarter ending September 30, 2024 was $0.02, a 97.26% decline year-over-year.
- TG Therapeutics 2023 annual EPS was $0.09, a 106.16% decline from 2022.
- TG Therapeutics 2022 annual EPS was $-1.46, a 44.49% decline from 2021.
- TG Therapeutics 2021 annual EPS was $-2.63, a 8.68% increase from 2020.
Earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.